A new mouse study shows high-dose aluminum adjuvant Imject Alum can induce liver fibrosis via inflammasome activation, ...

BSR’s updated csDMARD guideline introduces new evidence, whole-life-course recommendations, and risk-adaptive monitoring.

New test shows high sensitivity for tuberculosis, providing a faster, near-point-of-care option for early detection and ...

Distinct lipid changes in primary biliary cholangitis may signal inflammation and fibrosis. Discover how these findings could ...

JAK2 gene fusion appears across multiple CTCL types, shaping diagnosis and treatment opportunities. Learn more about its ...

Randomized split face trial suggests intradermal botulinum toxin A for post acne erythema reduces redness and sebum versus broadband light with similar short term safety.

A steep drop in the number of patients joining commercial clinical trials in the UK is limiting access to pioneering treatments and threatening the country’s global reputation for research, a new ...

Congress 2025 took place in Berlin, Germany, a dynamic epicentre known for its blend of innovation, culture, and historical ...

In this episode, Nicolas Girard discusses the latest developments in non-small cell lung cancer (NSCLC), with a focus on new ...

Plexiform neurofibromas (PNF) are benign, often infiltrative tumours of the peripheral nerve sheath classically linked to ...

Phase 3b WAYFINDER data show tezepelumab oral corticosteroid reduction in severe asthma, with nearly 90 percent reaching 5 mg ...

Hepatocellular carcinoma (HCC) is the sixth leading cause of cancer-related mortality worldwide.1 Despite therapeutic ...